Published in Am J Epidemiol on July 01, 1987
Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapy. AIDS (2009) 2.50
Female sex and IL28B, a synergism for spontaneous viral clearance in hepatitis C virus (HCV) seroconverters from a community-based cohort. PLoS One (2011) 1.38
Left truncation, susceptibility, and bias in occupational cohort studies. Epidemiology (2011) 1.29
Polymorphisms in toll-like receptor 4 and toll-like receptor 9 influence viral load in a seroincident cohort of HIV-1-infected individuals. AIDS (2009) 1.20
Weight loss and body mass index as predictors of HIV disease progression to AIDS in adults. Aquitaine cohort, France, 1985-1997. J Am Coll Nutr (2001) 1.18
A new approach to estimating AIDS incubation times: results in homosexual infected men. J Epidemiol Community Health (1992) 0.83
Time to seroconversion in HIV-exposed subjects carrying protective versus non protective KIR3DS1/L1 and HLA-B genotypes. PLoS One (2014) 0.80
Imputation of the Date of HIV Seroconversion in a Cohort of Seroprevalent Subjects: Implications for Analysis of Late HIV Diagnosis. AIDS Res Treat (2011) 0.80
Predicting time to threshold for initiating antiretroviral treatment to evaluate cost of treatment as HIV prevention. J R Stat Soc Ser C Appl Stat (2015) 0.75
Predicting the future of the AIDS epidemic and its consequences for the health care system of New York City. Bull N Y Acad Med (1988) 0.75
Sample size calculations for prevalent cohort designs. Stat Methods Med Res (2014) 0.75
Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science (1997) 18.10
The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants. Am J Epidemiol (1987) 17.36
Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature (1997) 15.49
Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet (2001) 13.32
The ALIVE study, a longitudinal study of HIV-1 infection in intravenous drug users: description of methods and characteristics of participants. NIDA Res Monogr (1991) 7.05
Validation studies for models projecting the risk of invasive and total breast cancer incidence. J Natl Cancer Inst (1999) 5.92
Randomized clinical trials. Perspectives on some recent ideas. N Engl J Med (1976) 5.86
Spectrum of AIDS-associated malignant disorders. Lancet (1998) 5.30
Risk factors for seroconversion to human immunodeficiency virus among male homosexuals. Results from the Multicenter AIDS Cohort Study. Lancet (1987) 4.33
Age-specific incidence rates of Alzheimer's disease: the Baltimore Longitudinal Study of Aging. Neurology (2000) 3.89
Predictors of the acquired immunodeficiency syndrome developing in a cohort of seropositive homosexual men. N Engl J Med (1987) 3.58
A randomized, community trial of intensive sexually transmitted disease control for AIDS prevention, Rakai, Uganda. AIDS (1998) 3.54
Biased selection of controls for case-control analyses of cohort studies. Biometrics (1984) 3.25
Statistical models for prevalent cohort data. Biometrics (1993) 3.16
Unrecognized human immunodeficiency virus infection in emergency department patients. N Engl J Med (1988) 3.08
Effect of HIV antibody disclosure on subsequent sexual activity in homosexual men. AIDS (1987) 3.01
Bacteroides fragilis subspecies in clinical isolates. Ann Intern Med (1977) 2.95
The locomotion of mouse fibroblasts in tissue culture. Biophys J (1970) 2.75
Detecting antibodies to human immunodeficiency virus in dried blood on filter papers. J Infect Dis (1987) 2.47
An analysis of comparative carcinogenesis experiments based on multiple times to tumor. Biometrics (1980) 2.45
Estimates of absolute cause-specific risk in cohort studies. Biometrics (1990) 2.42
Feasibility of pooling sera for HIV-1 viral RNA to diagnose acute primary HIV-1 infection and estimate HIV incidence. AIDS (2000) 2.37
Reductions in high-risk drug use behaviors among participants in the Baltimore needle exchange program. J Acquir Immune Defic Syndr Hum Retrovirol (1997) 2.36
Seroepidemiology of hepatitis B virus infection in the United States. 1976 to 1980. Am J Med (1989) 2.30
A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging. Neurology (1997) 2.30
Factors associated with prevalent human immunodeficiency virus (HIV) infection in the Multicenter AIDS Cohort Study. Am J Epidemiol (1987) 2.29
Minimum size of the acquired immunodeficiency syndrome (AIDS) epidemic in the United States. Lancet (1986) 2.28
Hodgkin's disease and Epstein-Barr virus. Altered antibody pattern before diagnosis. N Engl J Med (1989) 2.25
Natural history of human immunodeficiency virus infections in hemophiliacs: effects of T-cell subsets, platelet counts, and age. Ann Intern Med (1987) 2.24
Mortality associated with nosocomial urinary-tract infection. N Engl J Med (1982) 2.23
Loss of human immunodeficiency virus type 1 (HIV-1) antibodies with evidence of viral infection in asymptomatic homosexual men. A report from the Multicenter AIDS Cohort Study. Ann Intern Med (1988) 2.18
Increased risk of hepatocellular carcinoma in male hepatitis B surface antigen carriers with chronic hepatitis who have detectable urinary aflatoxin metabolite M1. Hepatology (1999) 2.16
Effects of mid-point imputation on the analysis of doubly censored data. Stat Med (1992) 2.09
Considerations in the evaluation of surrogate endpoints in clinical trials. summary of a National Institutes of Health workshop. Control Clin Trials (2001) 2.06
Visual memory predicts Alzheimer's disease more than a decade before diagnosis. Neurology (2003) 2.06
An outbreak of rubella among hospital personnel. N Engl J Med (1980) 2.05
Methods for quantitative vaginal flora studies. Am J Obstet Gynecol (1977) 2.05
Planning the duration of a comparative clinical trial with loss to follow-up and a period of continued observation. J Chronic Dis (1981) 2.03
Effect of colcemid on fibroblast motility. Exp Cell Res (1971) 2.01
Transmission of HIV-1 within a statewide prison system. AIDS (1988) 2.00
The implications of blood pressure variability for clinical and screening purposes. J Chronic Dis (1979) 1.98
Risk of human immunodeficiency virus (HIV-1) infection among laboratory workers. Science (1988) 1.97
Temporal trends of human immunodeficiency virus type 1 (HIV-1) infection among inmates entering a statewide prison system, 1985-1987. J Acquir Immune Defic Syndr (1989) 1.96
Prevalence of enteric pathogens in homosexual men with and without acquired immunodeficiency syndrome. Gastroenterology (1988) 1.93
Acquired immunodeficiency syndrome (AIDS)-free time after human immunodeficiency virus type 1 (HIV-1) seroconversion in homosexual men. Multicenter AIDS Cohort Study Group. Am J Epidemiol (1989) 1.90
Prevalence of dementia after age 90: results from the 90+ study. Neurology (2008) 1.88
Variance calculations and confidence intervals for estimates of the attributable risk based on logistic models. Biometrics (1990) 1.83
More on "Biased selection of controls for case-control analyses of cohort studies". Biometrics (1986) 1.76
Ocular manifestations of acquired immune deficiency syndrome. Ophthalmology (1989) 1.76
Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide. N Engl J Med (1983) 1.75
Isolation and identification of encapsulated strains of Bacteroides fragilis. J Infect Dis (1977) 1.74
Apolipoprotein E genotype and rate of decline in probable Alzheimer's disease. Arch Neurol (1996) 1.74
Reliability of the Blessed Telephone Information-Memory-Concentration Test. J Geriatr Psychiatry Neurol (1995) 1.72
Identification of site of urinary-tract infections by antibody-coated bacteria assay. Lancet (1979) 1.72
Relation of serum vitamins A and E and carotenoids to the risk of cancer. N Engl J Med (1984) 1.68
Immunogenicity and safety of measles vaccine in ill African children. Int J Epidemiol (1988) 1.67
Risk factors for surgical-wound infection following cardiac surgery. J Infect Dis (1987) 1.66
US nephrologists' recommendation of dialysis modality: results of a national survey. Am J Kidney Dis (2000) 1.65
Population-based monitoring of an urban HIV/AIDS epidemic. Magnitude and trends in the District of Columbia. JAMA (1992) 1.62
Application of DNA fingerprints for cell-line individualization. Am J Hum Genet (1990) 1.62
The influence of human immunodeficiency virus (HIV) infection on antibody responses to influenza vaccines. Ann Intern Med (1988) 1.60
Effect of T4 count and cofactors on the incidence of AIDS in homosexual men infected with human immunodeficiency virus. JAMA (1987) 1.60
Evolution of precancerous lesions in a rural Chinese population at high risk of gastric cancer. Int J Cancer (1999) 1.60
Modelling paired survival data with covariates. Biometrics (1989) 1.59
Factors influencing the age at natural menopause. J Chronic Dis (1987) 1.57
Gastric dysplasia and gastric cancer: Helicobacter pylori, serum vitamin C, and other risk factors. J Natl Cancer Inst (2000) 1.55
Prediagnostic serum selenium and risk of cancer. Lancet (1983) 1.54
Evaluation of human immunodeficiency virus seroprevalence in population surveys using pooled sera. J Clin Microbiol (1989) 1.54
Hepatitis B vaccine in health care personnel: safety, immunogenicity, and indicators of efficacy. Ann Intern Med (1984) 1.52
Does cardiac transplantation prolong life? A reassessment. Ann Intern Med (1972) 1.48
Validating and improving models for projecting the absolute risk of breast cancer. J Natl Cancer Inst (2001) 1.48
Serum beta-carotene, vitamins A and E, selenium, and the risk of lung cancer. N Engl J Med (1986) 1.46
Declining seroprevalence and transmission of HTLV-I in Japanese families who immigrated to Hawaii. Am J Epidemiol (1991) 1.46
Cytochalasin effects on BALB-3T3 fibroblasts: dose-dependent, reversible alteration of motility and cytoplasmic cleavage. Exp Cell Res (1971) 1.45
Density inhibition of motility in 3T3 fibroblasts and their SV40 transformants. Exp Cell Res (1971) 1.45
Variation in the duration of protection given by screening using the Pap test for cervical cancer. J Clin Epidemiol (1989) 1.44
Risk factors for infection at the operative site after abdominal or vaginal hysterectomy. N Engl J Med (1982) 1.44
Interpartner reliability of reporting of recent sexual behaviors. Am J Epidemiol (1991) 1.41
Early menopause in long-term survivors of cancer during adolescence. Am J Obstet Gynecol (1992) 1.41
Cervical and vaginal bacterial flora: ecologic niches in the female lower genital tract. Am J Obstet Gynecol (1978) 1.39
Detection of early antibodies in human immunodeficiency virus infection by enzyme-linked immunosorbent assay, Western blot, and radioimmunoprecipitation. J Clin Microbiol (1987) 1.37
Bacterial flora of the vagina: quantitative study. Rev Infect Dis (1984) 1.36
Infection with the human immunodeficiency virus: clinical manifestations and their relationship to immune deficiency. A report from the Multicenter AIDS Cohort Study. Ann Intern Med (1987) 1.33
No impact of repeated endoscopic screens on gastric cancer mortality in a prospectively followed Chinese population at high risk. Prev Med (2002) 1.33
Endocrine disorders in men infected with human immunodeficiency virus. Am J Med (1988) 1.32
On power and sample size for studying features of the relative odds of disease. Am J Epidemiol (1990) 1.32
Treatment of cytomegalovirus retinitis with ganciclovir. Ophthalmology (1987) 1.31
Biases in prevalent cohorts. Biometrics (1987) 1.31
Differences in the incidence of hepatitis B and human immunodeficiency virus infections among injecting drug users. J Infect Dis (1996) 1.30
Predictors of stroke risk in coronary artery bypass patients. Ann Thorac Surg (1997) 1.30
Two criteria for evaluating risk prediction models. Biometrics (2010) 1.29
Cell-substrate adhesivity. A determinant of cell motility. Exp Cell Res (1972) 1.29
Nonresponsiveness to hepatitis B vaccine in health care workers. Results of revaccination and genetic typings. Ann Intern Med (1986) 1.29
Methods for testing familial aggregation of diseases in population-based samples: application to Hodgkin lymphoma in Swedish registry data. Ann Hum Genet (2004) 1.28
Disability days associated with detection and treatment in a hypertension control program. Am J Epidemiol (1984) 1.28
Risk factors for nosocomial urinary tract infection. Am J Epidemiol (1986) 1.27
Risk factors for preterm premature rupture of fetal membranes: a multicenter case-control study. Am J Obstet Gynecol (1990) 1.25